Showing 1921-1930 of 23132 results for "".
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
https://reachmd.com/programs/neurofrontiers/beyond-the-brain-scan-blood-based-biomarker-tests-for-alzheimers-detection/29093/Tune in to learn how blood-based biomarker tests are being used to detect Alzheimer's disease.Noah Worcester 2024: Dr. Bhatia on Actinic Keratosis
https://reachmd.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-bhatia-actinic-keratosis/24585/Neal Bhatia, MD, FAAD, summarizes his lecture on actinic keratosis and photodynamic therapy at the 2024 Noah Worcester Dermatological Society meeting.Shifting Paradigms on Lentigo Maligna
https://reachmd.com/conferences/maui-derm-2024/shifting-paradigms-on-lentigo-maligna/20255/According to Ashfaq Marghoob, MD, current research supports individualizing treatment of lentigo maligna (LM) based on what is the best therapeutic option, from active surveillance to surgery to radiation to imiquimod.U.S. Preventive Services Task Force Updates Recommendations for Depression Screening in Adults
https://reachmd.com/programs/the-jama-report/us-preventive-services-task-force-updates-recommendations-depression-screening-adults/7900/[Read the Article] Depression is a common clinical problem, and is a leading cause of disability in adults. This condition is often under recognized and under treated, affecting individuals, families, businesses and society. The U.S. Preventive Services Task Force is an independent group of medicalVenetoclax and Palbociclib in AML: Exploring New Findings
https://reachmd.com/programs/on-the-frontlines-of-amlall/venetoclax-palbociclib-aml-findings/56352/Despite recent treatment advances, most patients with acute myeloid leukemia (AML)—especially those ineligible for intensive chemotherapy—ultimately relapse due to adaptive resistance to therapies like venetoclax. Ryan Quigley is joined by Dr. Jeffrey Tyner and Dr. Melissa Stewart to explorePsychiatric Comorbidity in Epilepsy: New Evidence from AES 2025
https://reachmd.com/programs/practical-neurology/psychiatric-comorbidity-in-epilepsy-new-evidence-from-aes-2025/39914/Ali Rafati, MD, MPH, Johns Hopkins Medicine, Baltimore, MD, and Churl-Su Kwon, MD, MPH, Columbia University Irving Medical Center, New York, NY, present new data from AES 2025 which reveal how depression and epilepsy are bidirectionally linked—and why neurologists must rethink screening and early inHow I Treat IgA Nephropathy: Lessons From the Case Files
https://reachmd.com/programs/kdigo-conversations-nephrology/title-how-i-treat-iga-nephropathy-lessons-from-the-case-files/37117/Join Dr. Dana Rizk (University of Alabama at Birmingham) as she leads a thought-provoking discussion on applying the updated KDIGO guidelines for IgA nephropathy (IgAN) treatment. She is joined by 2 distinguished guests: Dr. Gaia Coppock (University of Pennsylvania School of Medicine) and Dr. AndreNew FDA Approval for AD
https://reachmd.com/series/c-suite-chats/new-fda-approval-for-ad/29911/Phil Brown, MD, JD, Dermatologic Scientific Lead at Organon, talks about the importance of a new FDA-approved topical solution for treating atopic dermatitis.Advancing Precision Medicine in NSCLC: Real-World Impact of the PREDICT Initiative
https://reachmd.com/programs/project-oncology/advancing-precision-medicine-in-nsclc-real-world-impact-of-the-predict-initiative/39034/A 2025 study in Chest evaluated PREDICT, a precision medicine program at a large academic-community practice, designed to streamline testing and expand access to personalized treatment for non-small cell lung cancer (NSCLC). Hear from ReachMD's Ryan Quigley as he shares the key impacts of this approTurmeric Tonic as a Treatment in Scalp Psoriasis
https://reachmd.com/programs/practical-dermatology-focus-psoriasis/turmeric-tonic-as-a-treatment-in-scalp-psoriasis/24460/Peter Lio, MD, leads this analysis of a study on the effectiveness of a topical turmeric preparation for mild-to-moderate scalp psoriasis. While the trial results indicated a reduction in Psoriasis Area & Severity Index (PASI) scores and improved quality of life for participants using the turmer